MTOR and melanoma: Our last studies [8] have also demonstrated the efficacy of mTOR everolimus inhibitor in combination with MEK kinase inhibitor—AS-703026 or AKT kinase inhibitor—MK-2206 in the induction of apoptosis in melanoma cells.